BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10876829)

  • 1. Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect.
    Donnelly LF; Bisset GS; Adams DM
    Pediatr Radiol; 2000 Jun; 30(6):415-9. PubMed ID: 10876829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multistage ethanol sclerotherapy of soft-tissue arteriovenous malformations: effect on pulmonary arterial pressure.
    Shin BS; Do YS; Lee BB; Kim DI; Chung IS; Cho HS; Kim MH; Kim GS; Kim CS; Byun HS; Shin SW; Park KB
    Radiology; 2005 Jun; 235(3):1072-7. PubMed ID: 15833991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous management of peripheral vascular malformations: a single center experience.
    Türkbey B; Peynircioğlu B; Arat A; Canyiğit M; Ozer C; Vargel I; Balkanci F; Cil B
    Diagn Interv Radiol; 2011 Dec; 17(4):363-7. PubMed ID: 21204044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of sclerotherapy and embolization for arteriovenous and venous malformations.
    Bowman J; Johnson J; McKusick M; Gloviczki P; Driscoll D
    Semin Vasc Surg; 2013 Mar; 26(1):48-54. PubMed ID: 23932562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.
    Jain R; Bandhu S; Sawhney S; Mittal R
    J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation.
    Lee KB; Kim DI; Oh SK; Do YS; Kim KH; Kim YW
    J Vasc Surg; 2008 Nov; 48(5):1286-91. PubMed ID: 18829241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies.
    Mason KP; Michna E; Zurakowski D; Koka BV; Burrows PE
    Radiology; 2000 Oct; 217(1):127-32. PubMed ID: 11012433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy of craniofacial venous malformations: complications and results.
    Berenguer B; Burrows PE; Zurakowski D; Mulliken JB
    Plast Reconstr Surg; 1999 Jul; 104(1):1-11; discussion 12-5. PubMed ID: 10597669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts in diagnosis and treatment of venous malformations.
    Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interdisciplinary concept for classification and treatment of vascular anomalies in the head and neck].
    Ernemann U; Hoffmann J; Breuninger H; Reinert S; Skalej M
    Mund Kiefer Gesichtschir; 2002 Nov; 6(6):402-9. PubMed ID: 12447652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
    Su L; Fan X; Zheng L; Zheng J
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous sclerotherapy of congenital slow-flow vascular malformations of the orbit.
    Chiramel GK; Keshava SN; Moses V; Mammen S; David S; Sen S
    Cardiovasc Intervent Radiol; 2015 Apr; 38(2):270-9. PubMed ID: 25148921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-year experience treating vascular malformations with foam sclerotherapy.
    Markovic JN; Kim CY; Lidsky ME; Shortell CK
    Perspect Vasc Surg Endovasc Ther; 2012 Jun; 24(2):70-9. PubMed ID: 22918935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol sclerotherapy of peripheral venous malformations.
    Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
    Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
    Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
    Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the treatment of congenital vascular malformations using a multidisciplinary approach.
    Lidsky ME; Markovic JN; Miller MJ; Shortell CK
    J Vasc Surg; 2012 Nov; 56(5):1355-62; discussion 1362. PubMed ID: 22999048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.
    Lee CH; Chen SG
    Br J Plast Surg; 2005 Dec; 58(8):1073-8. PubMed ID: 16055097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathy after sodium tetradecyl sulfate sclerotherapy of venous malformations in children.
    Stuart S; Barnacle AM; Smith G; Pitt M; Roebuck DJ
    Radiology; 2015 Mar; 274(3):897-905. PubMed ID: 25271855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gross hemoglobinuria and oliguria are common transient complications of sclerotherapy for venous malformations: review of 475 procedures.
    Barranco-Pons R; Burrows PE; Landrigan-Ossar M; Trenor CC; Alomari AI
    AJR Am J Roentgenol; 2012 Sep; 199(3):691-4. PubMed ID: 22915413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.